The key is preventing infection and stopping post exposure viral loading through effective prophylactic treatment.
Accinelli, et. al. showed that parachute level benefit was realized when HCQ was given within 72 hrs of symptom onset. The correlation between mortality and time to treatment was even tighter than between mortality and comorbidities.
https://www.sciencedirect.com/science/article/pii/S1477893921002040
Hope this helps.
Accinelli, et. al. showed that parachute level benefit was realized when HCQ was given within 72 hrs of symptom onset. The correlation between mortality and time to treatment was even tighter than between mortality and comorbidities.
https://www.sciencedirect.com/science/article/pii/S1477893921002040
Hope this helps.